AMBAGON Trademark

Trademark Overview

On Tuesday, April 27, 2021, a trademark application was filed for AMBAGON with the United States Patent and Trademark Office. The USPTO has given the AMBAGON trademark a serial number of 90676106. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, August 23, 2024. This trademark is owned by AMBAGON THERAPEUTICS INC.. The AMBAGON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer; pharmaceutical products in the fields of oncology, neurology, and immunology
ambagon

General Information

Serial Number90676106
Word MarkAMBAGON
Filing DateTuesday, April 27, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, August 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer; pharmaceutical products in the fields of oncology, neurology, and immunology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAMBAGON THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDaly City, CA 94014
Party NameAMBAGON THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107

Trademark Events

Event DateEvent Description
Monday, May 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 30, 2021NEW APPLICATION ENTERED
Monday, August 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 22, 2021ASSIGNED TO EXAMINER
Wednesday, December 22, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 22, 2021NON-FINAL ACTION E-MAILED
Wednesday, December 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 14, 2023SOU EXTENSION 2 FILED
Monday, February 13, 2023SOU EXTENSION 1 FILED
Monday, February 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 14, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 22, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 22, 2024SOU EXTENSION 3 FILED
Thursday, February 22, 2024SOU EXTENSION 3 GRANTED
Friday, August 23, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 23, 2024SOU EXTENSION 4 GRANTED
Friday, August 23, 2024SOU EXTENSION 4 FILED
Friday, February 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ambagon pharmaceutical products neurology immunology oncology cancer treatment fields